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High protein diets may improve the maintenance of skeletal muscle mass in the elderly,
although it remains less clear what broader impact such diets have on whole body
metabolic regulation in the elderly. Non-targeted polar metabolomics analysis using
HILIC HPLC-MS was used to profile the circulating plasma metabolome of elderly men (n
= 31; 74.7± 4.0 years) who were randomized to consume for 10 weeks a diet designed
to achieve either protein (RDA; 0.8·g−1·kg−1) or that doubled this recommend intake
(2RDA; 1.6.g.kg−1). A limited number of plasma metabolites (n = 24) were significantly
differentially regulated by the diet. These included markers of protein anabolism, which
increased by the 2RDA diet, including; urea, creatine, and glutarylcarnitine. Whilst in
response to the RDA diet; glutamine, glutamic acid, and proline were increased, relative
to the 2RDA diet (p < 0.05). Metaboanalyst identified six major metabolic pathways to
be influenced by the quantity of protein intake, most notably the arginine and proline
pathways. Doubling of the recommended protein intake in older males over 10 weeks
exerted only a limited impact on circulating metabolites, as determined by LC-MS. This
metabolomic response was almost entirely due to increased circulating abundances
of metabolites potentially indicative of altered protein anabolism, without evidence of
impact on pathways for metabolic health.
Trial Registration: This trial was registered on 3rd March 2016 at the Australia New
Zealand Clinical Trial Registry (www.anzctr.org.au) at ACTRN 12616000310460.
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BACKGROUND
An adequate intake of dietary protein is essential for the
maintenance of health in the elderly. Yet considerable debate
exists as to howmuch protein is required for maintaining optimal
health in the aging population (1). Recent analysis has shown
that dietary intakes only meeting the World Health Organization
(WHO) recommended daily allowance (RDA) for dietary protein
(0.8 g·kg−1·d−1) increase the risk of progressive skeletal muscle
and muscular strength and/or function loss in the elderly (2–
4). This loss of muscle mass and function, known as sarcopenia,
is a major risk factor for the loss of independence, increasing
the likelihood for institutionalized care and mortality risk (5).
Recent meta-analysis of both intervention and cohort studies
provides additional evidence that diets that have protein intakes
greater than the RDA offer protection against muscle loss in the
elderly (6, 7). Recent expert opinions and consensus statements
have therefore suggested that older people should be aiming
to consume diets that provide well in excess of the RDA, with
recommendations ranging from 1.0 to 1.5 g·kg−1·d−1 (8–10).
Whilst there is emerging evidence of the potential benefits
of higher intakes of protein for maintenance of muscle mass
and function, the value and importance of dietary protein
in the context of various changes in digestive and metabolic
function, and the associated changes in liver and renal function,
in the elderly, require careful consideration (11, 12). It must
be considered whether elevated protein impacts on the already
established heightened risk and a wide range of complex diseases,
including many cancers, type 2 diabetes and cardiovascular
disease, that is experienced in the elderly (13, 14). To date,
analysis of the impact of dietary protein in the elderly on
metabolic disease risk is limited, with studies demonstrating an
adverse effect of diets rich in animal proteins, with the possible
exception of dairy protein (15, 16).
In order to define evidence-based protein intake
recommendations, it is therefore important to comprehensively
understand the metabolic implications of an increase in dietary
protein intake. These metabolic adaptations are undoubtedly
complex, as altered protein intake impacts on digestive
hormones, circulating amino acids and their metabolites, but
also exerts an as yet poorly defined impact on the human
gut microbiome (16, 17). A range of nutritional intervention
studies have utilized either targeted or untargeted metabolomics
approaches to profile the complex metabolic adaptations to diet
(18–20). Profiling of either plasma or urinary metabolites has
been able to identify major features of metabolic adaptation and
possible mechanisms by which health status is altered (12, 21).
These studies have also provided significant insight into a range
of metabolites that form predictive biomarkers of dietary intake
and habits that can be subsequently applied to the analysis of
habitual diet or adherence to a dietary intervention (22, 23).
Abbreviations: WHO, World Health Organization; RDA, recommended
daily allowance; HILIC-MS, hydrophilic interaction liquid chromatography-
mass spectrometry; BMI, body mass index; ANOVA, analysis of variance;
BCAAs branched chain amino acids; TMAO, trimethylamine N-Oxide; CVD,
cardiovascular disease.
Recently, we have reported on the primary outcomes of a
10-week intervention altering protein intake in older men, in
which it was demonstrated that a controlled whole food diet
intervention that doubled the WHO recommendation resulted
in reduced loss of skeletal muscle size and function, than a
diet only meeting the WHO protein recommendation (7). Thus,
in a secondary analysis, this study aimed to further examine
the impacts of a high protein diet on metabolic function
using a global/untargeted metabolomics analysis of polar
metabolites via hydrophilic interaction liquid chromatography-
mass spectrometry (HILIC-MS) (24). It is hypothesized that
a 10 week diet that doubles the RDA for protein (2RDA:
1.6 g·kg−1·d−1) in comparison to a diet that meets the
RDA (RDA: 0.8 g·kg−1·d−1) would result in a significant
alteration of polar metabolites related primarily to amino
acid oxidation and anabolism, with additional adaptation in
pathways related to metabolic regulation of carbohydrate and
lipid metabolic homeostasis.
METHODS
Ethics Statement
Written informed consent was obtained from all participants
before participation in the trial. The study was reviewed
and approved by the Southern Health and Disability Ethics
Committee (New Zealand; 15/STH/236) and was conducted
in accordance with the Declaration of Helsinki. The study
was prospectively registered with the Australian and New
Zealand Clinical Trial Registry (www.anzctr.org.au) as
ACTRN12616000310460 on March 9, 2016.
Participants
Healthy elderly men, ≥70 years were recruited through
advertisements to participate in the study. All participants
were free-living individuals who had a body mass index (BMI;
kg/m2) ranging from 18 to 35. All were non-smokers who
did not consume any dietary supplements 1 month before
participating in the study. Exclusion criteria to those potential
participants were those who consumed a restricted diet, including
vegetarians or with self-reported food allergies (e.g., nuts, fish,
dairy). Further exclusion was applied to those with a prior
history of cancer, diabetes, thyroid disease or conditions affecting
neuromuscular function.
Experimental Design
The design of this study has been previously described in
Mitchell et al. (7). Participants were randomized into two
groups (equal allocation ratio) where they either received a
controlled diet of 0.8 protein kg−1·d−1 (RDA) or 1.6 g protein
kg−1·d−1 (2RDA) for 10 weeks. All meals consumed by the
participants during the 10-week study were provided. Energy
from fat was standardized (28–31% of energy), with the
difference being made up of carbohydrates. All diets adhered
to Eating and Activity Guidelines for New Zealand (25). Adults
met the recommendations for intake of fruit and vegetables.
All participants completed dietary records to ensure all food
provided was consumed, and food selection was adjusted to
Frontiers in Nutrition | www.frontiersin.org 2 December 2019 | Volume 6 | Article 180
Durainayagam et al. Nutritional Interventions for Older Adults
participants’ preferences to maintain high compliance. Any
non-study food consumed was also asked to be recorded.
The energy content of the intervention diet was individually
calculated to match participants estimated energy needs based
on the Harris-Benedict equation (26) and adjusted for physical
activity, which was assessed by wrist-worn accelerometers (Fitbit
Charge HR). The estimated energy needs were calculated before
the intervention and adjusted fortnightly based on participant
weight maintenance and satiety to ensure participants consumed
adequate protein relative to energy intake. Throughout the study
protein and energy were distributed between breakfast, lunch and
dinner as 30, 30, and 40%, respectively. During the intervention,
participants were instructed to maintain their normal lifestyle,
and prepared meals were delivered to their homes. All testing
was conducted at the University of Auckland Nutrition and
Mobility Clinic.
Metabolomics Analysis
Fasted plasma was collected pre-intervention and at the
completion of 10 weeks of diet intervention. Extraction of
metabolites was performed using a previously described bi-
phasic method (27). Briefly, 100 µl of plasma was mixed with
800 µl of cold (−20◦C) CHCl3/MeOH (50:50, v/v), agitated
for 30 s and stored at −20◦C for 60min to allow for protein
precipitation. Subsequently, 400 µl water was added, the mixture
was vortexed (2 × 15 s) and centrifuged for 10min at 14,000
rpm and 4◦C to separate the aqueous (upper) and organic
(lower) phases.
The lower organic phase is the lipid portion of the extract
and was not analyzed as the interest in this clinical trial was
around the impact of prolonged increased protein intake on the
metabolome. Thus, any changes are likely to occur in the polar
metabolome rather than the lipidome.
The aqueous phase (200 µl) was collected, dried under a
stream of nitrogen and reconstituted in 200 µl of acetonitrile:
water (50:50, v/v) containing 10µg/ml d2-tyrosine as an
internal standard. Samples were placed in the LC-auto-
sampler at 4◦C for HILIC-MS analysis. Blank procedure
samples were prepared exactly as the samples, but plasma
was replaced with Milli-Q water. To avoid any systematic
analytical effects, samples were randomized before analysis.
To verify and/or maintain data quality within each mode,
a QC sample (comprising a pooled extract of all samples)
was also injected once for every 10 samples. Retention time,
signal/intensity, and mass error of internal standards were
monitored constantly to check instrument response variability
and retention time shifts.
Plasma extracts were analyzed by HILIC LC-MS (Thermo
Fisher Scientific, Waltham, MA, USA) using both positive and
negative ionization modes. HILIC-MS conditions have been
previously described in Fraser et al. (24). Briefly, compounds
were separated using a 5µm ZIC-pHILIC column (100 ×
2.1mm, 5µm; Merck Darmstadt, Germany) eluted with solvent
A: acetonitrile with 0.1% formic acid, and solvent B: 16mM
ammonium formate in water, at a flow rate of 250 µl/min. Initial
conditions of the solvent gradient were set at 97:3 (A:B), which
was held for 1min, where after that the gradient was changed
linearly to give a ratio 10:90 (A:B) at 14.5min and maintained
till 17min. At this time and up to 24min, the column was
allowed to return to initial conditions and re-equilibrate. The
column eﬄuent was connected to an electrospray source of a
high-resolution mass spectrometer (Exactive Orbitrap, Thermo,
San Jose, CA, USA). Mass spectral data were collected in profile
data acquisition mode covering a mass range of m/z = 55–1,100
with a mass resolution setting of 25,000 and a maximum trap
fill time of 250ms using the Xcalibur software package (Thermo,
San Jose, CA, USA).
Data processing consisted of a series of procedures aimed
at converting raw mass spectrometry data to data matrices
suitable for further statistical analyses. Peak detection, alignment,
grouping, and noise elimination were performed using XCMS
software (28). The resultant peak intensity table was subjected
to run-order correction and batch normalization utilizing
pooled QC samples and applying the lowess regression model
(29). This was evaluated on the open-source online platform
Workflow4metabolomics (https://workflow4metabolomics.org)
(30). Finally, features with a CV of >30% within the pooled QC
samples were removed.
Statistical Analysis
Principal component analysis (PCA) was used to validate the
quality of the analytical system performance and observe possible
outliers using the commercial package SIMCA-P+ version
14.1 software (Umetrics, Umea, Sweden). Two-way repeated
measures ANOVA was used to determine differences in groups
with time (pre vs. post) as a repeated factor and diet as
a fixed factor using R (version 3.4.2). Post-hoc comparisons
were conducted by Holm-Sidak corrections. False discovery rate
adjustment of P-values (FDR) was applied using the Benjamini-
Hochberg method.
Peak Identification
Peak identification was performed by verifying the accuracy
of mass measurements, the retention time and the tandem
mass spectrometry results against an in-house database, which
contained over 600 authentic standard compounds. Where
a feature did not match the library, the molecular and co-
eluting ions were manually inspected. The source voltage
applied created a small amount of source induced fragmentation
which could be used to facilitate annotation of the unknown
features. Thus, pseudo MS2 spectral data was validated by
inspecting each metabolite for perfectly co-eluting fragment
and molecular ions. These were matched to the MS/MS
data provided on public libraries such as METLIN (31) and
the Human Metabolome Database (HMDB) (32). The use
of pseudo MS2 spectral data to validate the molecular ion
has been previously described as an acceptable approach (33)
and has been applied in large cohort trials such as the
HUSWERMET project (34). Each metabolite was assigned a
confidence level defined by the Metabolomics Standard Initiative
(35). Therefore, the level 2 annotation is based on co-eluting
accurate mass fragment ions observed with the accurate mass of
the molecular ion.
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Network Analysis and Metabolic Pathway
Construction
MetaboAnalyst (version 4.0) was used for pathway enrichment
analysis utilizing the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database, which can provide valuable information
by integrating two pathway analysis approaches; pathway
enrichment analysis and pathway topology analysis (32). The
hypergeometric test was selected to evaluate whether a particular
metabolite set was represented more than once (36). The relative-
betweenness centrality algorithm was applied for pathway
topology analysis measuring the numbers of shortest paths going
through a node in the network. This takes into consideration
the global network structure, not only the immediate neighbor
of the current node (37). The acquired impact value represents
the accumulative percentage of importance for the matched
metabolite nodes involved in a pathway. Network construction
was performed by Cytoscape (version 3.4.0) (38) utilizing the
plugin Metscape and topological parameters were analyzed using
the network analyser tool (39). To confirm the most important
metabolites of the network, two well-established node centrality
measures were used to estimate node importance; the degree of
each node and betweenness.
RESULTS
Subject Characteristics and Dietary Intake
The participants were randomly assigned to either the RDA
(n = 16) or 2RDA (n = 15) diet; of these one subject
withdrew his consent before the start of the dietary intervention
(RDA group) and one subject from the 2RDA group did not
complete the 10-week intervention due to failed diet compliance
(Table 1). Based on dietary records, compliance was 98.9% for
both protein and energy intake in the RDA group and 97.5%
and 98.4% for protein and energy intake, respectively in the
2RDA group, with no compliance difference between the two
groups. As previously reported, both groups shared a small
energy deficit of 209 ± 213 and 145 ± 214 kcal/d in the
RDA and 2RDA groups, respectively, with no energy deficit
difference between the two groups. Detailed changes in body
composition and macronutrient information can be found in
Mitchell et al. (7).
Metabolomics Analysis
The stability and reproducibility of the current data were
evaluated by the QC samples measured during the whole
experimental period. PCA score plot representation analysis
on the whole data matrix, which included all features (m/z
and retention time) showed no obvious run-order effects
for metabolite profiles obtained in positive and negative ion
modes (Supplementary Figure 1). This result demonstrated
good stability and reproducibility in the current metabolomic
dataset. After data processing, 170 and 275 features were detected
in positive and negative ionizationmode respectively, which were
pooled together to visualize in a volcano plot (Figure 1). The
total number of features (445) were separated by significance
(post-intervention t-test) and fold change (>1.2).
TABLE 1 | Physical characteristics of participants.
RDA
(n = 15)
2RDA
(n = 14)
Age (years) 74.9 ± 1.1 73.8 ± 0.9
Height (cm) 171.8 ± 2.0 172.1 ± 1.6
Weight (kg) 83.9 ± 5.4 83.0 ± 2.4
BMI (kg/m2) 28.2 ± 1.4 28.0 ± 0.9
Values are means± standard error of the mean. The RDA is 0.8 g protein·kg−1·d−1, 2RDA
is 1.6 protein·kg−1·d−1. BMI, Body mass index, RDA, Recommended dietary allowance.
Two-way repeated measure ANOVA revealed 24 metabolites
exhibiting changes between and within diet groups (p <
0.05). These differentially regulated metabolites are classified
by using the four levels of certainty as defined by Sumner
et al. (35) (Supplementary Table 1). After 10 weeks, nine
metabolites demonstrated increases only within the 2RDA
group. Glutrylcarnitine (Figure 2A), trigonelline (Figure 2B),
trimethylamine N-Oxide (TMAO; Figure 2C), glycocyamine
(Figure 2D), creatinine (Figure 2E), and urea (Figure 2F) all
increased within the 2RDA group (p < 0.05 each, respectively),
whereas there were no changes in the RDA group for these
metabolites. Furtheremore, these metabolites were significantly
elevated in the 2RDA group compared to the RDA group post-
intervention (p < 0.05 each, respectively). Two pyrimidines,
dihydrothymine (Figure 2G) and uridine (Figure 2H), along
with an unknown metabolite (Supplementary Figure 2A)
increased within the 2RDA group after 10 weeks but were not
higher than the RDA group at the post-intervention stage (p <
0.05 each, respectively).
Ten metabolites demonstrated changes within the RDA group
after the 10 week intervention. Tryptophan (Figure 3A), creatine
(Figure 3B) and methylimidazoleacetic acid (Figure 3C) all
reduced within the RDA group and post-intervention were lower
in the RDA group compared to the 2RDA group (p < 0.05 each,
respectively). Furthermore, the 2RDA diet increased the level of
tryptophan (p = 0.04) and creatine (p = 0.001) after the 10 week
intervention. Glutamine (Figure 3D), uric acid (Figure 3E) and
unknown metabolite M160T639 (Supplementary Figure 2B)
increased within the RDA group with not changes obeserved
within the 2RDA group (p < 0.05 each, respectively). Post-
intervention, the RDA group was higher than the 2RDA
group for uric acid (p = 0.02) and glutamine (p = 0.03).
Threonine (Figure 3F) and glutamic acid (Figure 3G) along with
unknown metabolite M145T531 (Supplementary Figure 2C)
increased only within the RDA groupwith no difference observed
between groups post-intervention (p < 0.05 each, respectively).
2-aminoadipic acid (Figure 3H) did not show any changes within
diet groups but was elevated in the 2RDA group compared RDA
group post-intervention (p= 0.04).
At baseline, four metabolites were different among the 30
participants, which converged at the end of the 10-week period.
Lenticin (Figure 4A) and proline (Figure 4B) increased within
the RDA group (p < 0.05 each, respectively). Indoleacrylic acid
increased within both the RDA (Figure 4C; p = 0.03) and 2RDA
Frontiers in Nutrition | www.frontiersin.org 4 December 2019 | Volume 6 | Article 180
Durainayagam et al. Nutritional Interventions for Older Adults
FIGURE 1 | Volcano plot analysis of metabolite changes after 10 weeks dietary intervention. Red dots denote significant (p < 0.05) and fold change (>1.2) features.
Blue dots represent significant features (p < 0.05), black dots designate fold change (>1.2), and clear dots represent neither no significance (p > 0.05) or fold change
of <1.2.
group (p = 0.003). Arginine (Figure 4D) was also different at
baseline (p = 0.02) but demonstrated no changes within diet
and at the post-intervention stage. Dimethylglycine (Figure 4E)
decreased in both diet groups with no pre or post difference (p <
0.05 each, respectively).
Pathway Analysis
Six pathways were statistically significant as determined
by MetaboAnalyst; five pathways relating to amino acid
metabolism are ranked in descending order in Table 2. Arginine
and proline metabolism was the most significant with eight
identified metabolites. The pathways were composed of
metabolites that increased within the RDA group such as;
glutamine, glutamate, and proline. In addition, metabolites that
increased within 2RDA group; urea, glycocyamine, creatinine,
creatine, and tryptohan were also important components in the
pathways identified.
Metabolic Network Analysis
Figure 5 displays a network visualization, where it
demonstrates the centrality of glutamine, glutamic acid,
arginine, and uridine and their connectivity to an array of
metabolites and enzymes. These metabolites are considered
hub metabolites based on measures of degree >10 and
betweenness centrality (>0.1), where they are not only
components of pathways but are also integral to pathway
performance (Table 3).
DISCUSSION
Comprehensive polar metabolomics analysis via HILIC-LCMS
was applied to the plasma samples from elderly males who
consumed a diet that contained foods to achieve the RDA for
protein or when the diet was manipulated to achieve twice the
RDA (2RDA). The key finding was centered on amino acid
metabolism, with very few significant changes in metabolites not
directly related to amino acid metabolism. Eleven metabolites
were different between the RDA and 2RDA groups at the
end of the interevention. Adherence to a diet that met the
minimum dietary recommendations (RDA) resulted in increased
circulatory concentrations of a limited subset of non-essential
amino acids, including; glutamine, glutamic acid, and proline.
These amino acids, along with arginine, have been identified
as integral hubs where metabolic pathways overlap and may
be indicative of increased overall tissue catabolism. With an
increased protein consumption (2RDA), there were alterations in
the circulatory metabolome consistent with increased amino acid
flux and nitrogenous oxidative metabolism. There was also a shift
in circulating metabolites that may be indicative of induction of
anabolic pathways (40, 41). This metabolomic analysis provides
evidence of how changes in dietary protein may impact the
regulation of muscle mass. In this study, these results provide
support for our previously published findings of increasedmuscle
mass and physical strength in the older men who consumed the
higher protein diet (7).
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FIGURE 2 | Metabolites which increased in the 2RDA diet. Box and whisker plot showing median, first, and third quartiles, and maximum and minimum values.
(A) glutrylcarnitine, (B) trigonelline, (C) TMAO, (D) glycocyamine, (E) creatinine, (F) urea, (G) dihydrothymine, and (H) uridine increased within the 2RDA group.
#denotes the significant differences of metabolites between 2RDA and RDA. *Represents the significant differences of metabolites between pre and post intervention
within each group.
Arginine and Proline Metabolism
Greatest statistical discrimination between the diets related
to arginine and proline pathways, which comprised of eight
metabolites with fold changes ranging between 1.2 and 2.7. The
high centrality of arginine places it as a key metabolic hub, acting
as a precursor for downstream targets. In this pathway, arginine
Frontiers in Nutrition | www.frontiersin.org 6 December 2019 | Volume 6 | Article 180
Durainayagam et al. Nutritional Interventions for Older Adults
FIGURE 3 | Metabolite responses to 2RDA or RDA after 10 week intervention. Box and whisker plots showing median, first, and third quartiles, and maximum and
minimum values. (A) tryptophan, (B) creatine, (C) methylimidazoleacetic acid increased in the 2RDA group. (D) glutamine (E) uric acid, (F) threonine, (G) glutamic acid
all increased in the RDA group. (H) 2-aminoadipic acid was higher in the 2RDA group compared to the RDA group. #denotes the significant differences of
metabolites between 2RDA and RDA. *Represents the significant differences of metabolites between pre and post intervention within each group.
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FIGURE 4 | Pre-intervention metabolite differences. Box and whisker plots show median, first, and third quartiles, and maximum and minimum values. There were
four metabolites which exhibited pre-intervention differences (A) lenticin, (B) proline, (C) indoleacrylic acid, and (D) arginine. (E) dimethylglycine decreased in both diet
groups. #denotes the significant differences of metabolites between 2RDA and RDA. *Represents the significant differences between pre and post-intervention within
each group.
is converted by arginase-1 to urea and is also the precursor
to creatine through the intermediate glycocyamine. Urea and
creatine are widely used markers of protein intake (42). Arginine
is also important in overall skeletal muscle protein balance
as a key substrate for nitric oxide, an endogenous regulator
of vascular homeostasis (43). Evidence suggests nitric oxide
is integral to skeletal muscle contractile function, blood flow,
and glucose homeostasis, further highlighting the importance
of arginine (44). Also part of the arginine-proline pathway is
glutamic acid, the precursor to proline, which increased 3-fold
in the RDA group. High levels of proline have been previously
implicated as a risk factor for sarcopenia and frailty (45).
Therefore, in the current study, the post-intervention difference
between diet groups by the observed approximate 30% elevations
in urea, glycocyamine, and creatine in the 2RDA group together
with the alterations in the arginine and proline pathways, is
indicative of a metabolomic milleau potentially favorable to
sustaining anabolism.
Glycine, Serine, and Threonine Metabolism
Five metabolites from the glycine, serine, and threonine
metabolism pathway were regulated by protein intake, including;
glycocyamine, creatine, and tryptophan all of which were higher
in the 2RDA group compared to the RDA group. Of these, it
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TABLE 2 | Description of the total number of compounds in the pathway.
Pathway
name
Total
compounda
Hitsb Raw pc –Log (p) Impactd
Arginine &
proline
metabolism
77 8 2.57E-08 2.06E-06 0.356
Aminoacyl-
tRNA
biosynthesis
75 6 1.03E-05 0.00041 0.0563
Glycine,
serine &
threonine
metabolism
48 5 1.80E-05 0.00048 0.137
Pyridine
metabolism
60 4 0.00821 0.0164 0.0355
Nitrogen
metabolism
39 3 0.00271 0.0372 0.000
Glutamine &
glutamate
metabolism
11 2 0.00279 0.0372 0.139
Alanine,
aspartate &
glutamate
metabolism
24 2 0.0132 0.151 0.384
aTotal compound is the number of compounds involved in the pathway.
bHits is the matched number from the user uploaded data.
cThe raw p is the original p-value calculated from the enrichment analysis.
d Impact value is calculated from pathway topology analysis for comparison among
different pathways. It represents the cumulative percentage of importance for thematched
metabolite nodes involved in a pathway. The importance of each metabolite node is
calculated from centrality measures and represents the percentage with regard to the
total pathway importance.
has been shown that glycine, serine, and threonine metabolism
are central to providing precursors for the synthesis of proteins,
nucleic acids, and lipids (46). Threonine was increased by
60% in the RDA group and has been shown to follow the
changes of branch chain amino acids (BCAAs) in situations
of muscle catabolism (47, 48). Dimethylglycine which was
identified to be part of the same cycle is produced from
betaine and metabolized to glycine, decreased in both RDA and
2RDA groups. Dimenthylglycine is a degradation product for
one-carbon metabolism, which supports multiple physiological
processes such as; amino acid metabolism, and biosynthesis of
purines (46). Tryptophan has multiple biological roles and whilst
it has not been directly implicated in tissue anabolism, it is the
precursor of serotonin and reflected in mood and cognition (49).
Therefore, while its role is difficult to ascertain, tryptophan’s
fasting plasma levels may be of significant interest as an indicator
of nutritional status beyond anabolism. Contrasting observations
have been reported for relationships between tryptophan and
skeletal muscle. Moaddel et al. (50) associated higher levels
of tryptophan with low muscle quality, while in Toyoshima
et al. (45) tryptophan was lower in sarcopenic participants.
Our findings for tryptophan are in agreement with Toyoshima
et al. (45) where the 2RDA group increased the plasma level of
tryptophan by 16% and was higher than the RDA group at the
end of the intervention.
Aminoacyl-tRNA Biosynthesis, Nitrogen
Metabolism, and Pyrimidine Metabolism
Metabolism of the aminoacyl-tRNA biosynthesis and nitrogen
metabolism pathway also discriminated between 2RDA and RDA
with six and three identified metabolites, respectively. Glutamine
and glutamic acid are components of both aminoacyl-tRNA
and nitrogen metabolism, which along with threonine, proline,
and arginine (which demonstrated a trend), increased in the
RDA group. Aminoacyl-tRNA substrates are the essential first
steps for protein synthesis. Dysregulation of these pathways has
been linked with aging muscle (51). Based on our previous
demonstration of reduced appendicular lean mass in the RDA
group (7), these data suggest the circulatory alterations both
aminoacyl-tRNAs and nitrogen metabolism are reflective of this
loss of muscle mass.
Uridine, dihydrothymine, and urea, were metabolites
identified to be components of pyrimidine metabolism where
glucose and glutamine serve as precursors. These metabolites
were each increased in the 2RDA group, by at least 60%.
Pyrimidine metabolism, is integral to cell cycle regulation, and
tightly linked to the ability of the cell to acquire nutrients,
generate metabolic energy, and to drive anabolism, including
nucleotide/nucleic acid biosynthesis (52). Glutamine is an
important component of muscle protein, and helps repair
and build muscle (53). Furthermore, glutamine deficiency
stimulates cell apoptosis, which may thereby trigger a low-level
inflammatory process and increase the rate of sarcopenic
progression (54). In times of catabolic stress, glutamine derived
by de novo synthesis from skeletal BCAAs are used to form
glutamic acid. Glutamic acid displays remarkable metabolic
versatility being highly abundant in liver, kidney, skeletal muscle,
and the brain, illustrating its utility (55). In this study, glutamine
increased 3-fold and glutamic acid was elevated by 30% in the
RDA group. which is concomitant with physical changes of
reduced lean muscle (7).
Markers of Specific Diet Consumption
The findings of the current study are complex in that there were
observed baseline differences revealed by the 2-way repeated
measures ANOVA, prior to the dietary interventions, in a small
subset of metabolites. This was despite the cohort being relatively
homogenous in terms of age, BMI, background diet and general
metabolic and cardiovascular health. It is unclear whether these
differences are then reflective of the complexity associated with
inter-individual variability or indicative of a difference in habitual
diet or associated lifestyle factor(s). Notable amongst the pre-
intervention differences was lenticin, found in lentil extracts
and is detected in blood after lentil consumption (56). These
observed baseline differences were normalized with the 10 week
intervention, as the participants adhered to the well-designed
meals matched for micronutrients, macronutrients, and food
structure, except protein.
In this study, uric acid, the end product of purine metabolism,
was increased by 30% in the RDA diet. Increased concentrations
of uric acid is a causative factor in gout (57), where previously, it
has been postulated that higher consumption of dietary protein
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FIGURE 5 | Global metabolic network pathways. Nodes correspond to the identified plasma metabolite, and edges indicate a significant correlation between nodes.
Red hexagons represent inputted metabolites; pink hexagons represent compounds, blue circles represent genes, green quadrangles represent enzymes, gray
quadrangles represent reaction paths.
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TABLE 3 | Topological parameters of key metabolites.
Metabolite KeggID Degree Betweenness
centrality
Pathways
Glutamic
acid
C00025 39 0.670 Arginine & proline
metabolism,
Aminoacyl-tRNA
biosynthesis, Nitrogen
metabolism, Glutamine &
glutamate metabolism,
Alanine, aspartate &
glutamate metabolism
Glutamine C00064 19 0.645 Arginine & proline
metabolism,
Aminoacyl-tRNA
biosynthesis, Nitrogen
metabolism, Glutamine &
glutamate metabolism,
Alanine, aspartate &
glutamate metabolism,
Pyrimidine metabolism
Arginine C00062 16 0.444 Argine & proline
metabolism,
Aminoacyl-tRNA
biosynthesis
Uridine C00299 12 1.000 Pyrimidine metabolism
The degree of a node is the number of edges associated with it, and the betweenness
centrality of a node is the number of shortest communication paths between different
pairs of nodes.
increases uric acid excretion, thereby reducing circulatory uric
acid (58, 59). TMAO is generated from choline, betaine, and
carnitine by gut microbial metabolism, increased in the 2RDA
group by 5-fold with no change in the RDA group. The
specific increase of TMAO in the 2RDA is similar to previous
observations of well-known protein sources; fish (60) and meat
(61). Whilst, the role of TMAO remains speculative toward gut
health and CVD risk (62), the present finding suggests it can be
regarded as a marker of high protein intake.
Limitations
This trial applied an untargeted HILIC-MS approach to cover
polar metabolites, yet the metabolome is vast in number and
diverse in nature. There is opportunity for future studies
to implement more comprehensive untargeted metabolomics
analysis to cover greater diversity of the metabolome by utilizing
reverse phase (RP)-MS and lipidomic analysis and to include
other biological matricies such a urine and feces. These types
of analysis could provide a more holistic understanding of
the impact of nutritional interventions on metabolism and
physiology. Lastly, while the findings of this discovery study can
be explained and make sense biologically, it is recommended
that discovery studies should be followed-up with a targeted
approach to quantify findings and replicated in independent and
larger cohorts.
CONCLUSIONS
In the current study, untargeted metabolomics analyses were
carried out to discriminate the polar plasma metabolome
changes associated with a prescribed protein intake at RDA
(0.8 g·kg−1·d−1) or 2RDA (1.6 g·kg−1·d−1) for 10 weeks.
Post-intervention, two-way repeated measures ANOVA revealed
metabolites of increased amino acid flux such as urea and
creatinine were higher in the 2RDA diet compared to the
RDA diet. Further metabolites were different between the two
diet groups such as tryptophan and creatine and glutamine,
which are components of the arginine and proline metabolism
and nitrogen metabolism. These metabolites and pathways
are indicative of changes in key aspects of skeletal muscle
metabolism, which showed a good association with reduced
maintenance of mass and function (7). Conversely, in the
2RDA group biomarkers of increased amino acid flux were
increased, such as urea and uridine. Along with pathways
these are involved in (glycine, serine, and threonine metabolism
and aminoacyl-tRNA metabolism) allow us to speculate these
alterations in metabolites are indicative of induction of tissue
anabolism. Overall, this study demonstrated shifts in the
metabolome induced by a higher protein diet is very limited
in its metabolomic impact. Of those few metabolites that
were statistically altered, it can be suggested that these are
indicative of a possible induction of pathways supporting
tissue anabolism and maintenance of muscle mass. In contrast,
reducing protein intake to current minimum requirements
resulted in a more catabolic metabolomic profile, potentially
congruent with changes in skeletal muscle phenotype previously
reported in the same cohort.
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